Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aixinone tablets for stable angina (phase II)
CTR20131550Phase 2Completed
- Sponsor
- Shenzhen Neptunus Pharmaceutical
- Start
- Mar 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Aixinone in coronary arteriosclerosis, angina pectoris, sponsored by Shenzhen Neptunus Pharmaceutical. Started Mar 2014; status: completed.
02
Drugs
Aixinone
03
Conditions
coronary arteriosclerosisangina pectoris
Beyond the preview
Go deeper on CTR20131550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131550.